Julien Lefranc (@LefrancJu) header
Julien Lefranc (@LefrancJu) profile picture

#Medchem @merckgroup former @bayerpharma interested in #cancer #kinaseinhibitors #degraders only personal views Reviewer @drughunter

Darmstadt, Germany
Joined November 2017
Very nice to be back in Bristol for the CDT Summer Conference. A lot of great science presented by very talented PhD students ! Congratulations to @JonathanClayden, @VarinderAggar11 and @BCS_CDT
1
2
1
23
4,211
I keep being amazed by the work from @Rev_Medicine Here is a example from their last patent. This work is again pushing medicinal chemistry out of out comfort zone. 6 chiral centers, 1 atropisomer , a spiro and an aziridine ! Congratulations to @Les_Burnett and all the Team!
1
5
20
1,409
Final Session for the New drugs on the horizon @aacr #AACR23. SMOLs, molecular glue, ADC. @MerckHealthcare @MonteRosaTx @elevationonc @TangoTxOncology
1
10
671
Excellent second session for New Drugs on the horizon !! @AACR #aacr23. Degrader, bi-specific antibody, molecular glue, and covalent inhibitor !! @C4Therapeutics @Amgen @Rev_Medicine Flare Therapeutics !
8
24
4,313
Great New Drugs on the Horizon session @AACR #aacr23 with ADC, CAR-T, Protac and SMOL for IO !!! @abbvie @CRISPRTX @ArvinasInc @Bayer @DKFZ
8
27
8,760
This is it !!! @AACR #AACR23. stay tuned alao with @drughuntersite
9
991
Here we are !! KRAS session #AACR23 @AACR
1
7
787
Let s start the second day #AACR2023 with a very exciting educational on degraders @danetteldaniels @ChrisNasveschuk @FleurMFerguson
1
1
9
925
Excellent way to finish the day yesterday at #FIMC2023 @GDCh_aktuell . What a performance from @DirkTrauner with a journey in photopharmacology and natural product synthesis.
12
1,152
Great scientific talks in the #NextGenMedChem session at #fimc2023 with Stefanie Flohr @Novartis @crwfrd_SF @genentech and Sophie Bertrand @gsk
3
5
711
More science from the #NextGenMedChem ! Excelletalk from @Franca_klg !
4
11
819
let s start Day 2 #FIMC2023 with @georg_e_winter !! @GDCh_aktuell
2
3
496
My colleague Andreas @MerckHealthcare now on stage at the #FIMC2023 @GDCh_aktuell
1
6
681
First PI3K inhibitor approved outside oncology ! Pharming’s Leniolosib is the first treatment approved by the @US_FDA for APDS. Great news for patients ! Congrats to colleagues @Novartis for this discovery. pharming.com/news/pharming-a…
2
10
45
4,690
Check out this great article from my colleagues @MerckHealthcare on the discovery of the highly mutant selective KIT inhibitor M4205 ! Excellent work driven by clinical need ! #VibrantMedChem #VibrantChemistry @merckgroup @ACSBioMed pubs.acs.org/doi/full/10.102…
14
1,448